88 msSDANN was 88 ms in the poorly controlled type 2 diabetes group.
Cameroundiabète de type 2publié 2018BMC research noteseurope_pmcdocument de 8 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 754 evidences · page 29 / 71
88 msSDANN was 88 ms in the poorly controlled type 2 diabetes group.
Cameroundiabète de type 2publié 2018BMC research noteseurope_pmcdocument de 8 observations
36,5 %The prevalence of hypertension was 36.5% among men in the rural Fulani population of Cameroon aged ≥ 20 years.
Camerounhypertension artérielleobservé 2013publié 2017Journal of health, population, and nutritioneurope_pmcdocument de 3 observationsDOI 10.1186/s41043-017-0112-2
39,52 msSDNN was reduced in patients with hyperthyroidism (39.52) compared to controls (63.75), with a p-value of 0.2.
Camerounhyperthyroidismpublié 2018BMC research noteseurope_pmcdocument de 6 observations
24 700 000 IU/mLIn coinfected patients, the median HBV viral load was 2.47 x 10^7 IU/mL.
Camerounhépatite Bpublié 2010BMC Public HealthOpenAlexdocument de 6 observationsDOI 10.1186/1471-2458-10-105
At day 30, all participants were asymptomatic.
CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838
2,08 genotypes_per_infectionThe multiplicity of infection (MOI) was 2.08 in Mfou, Cameroon.
CamerounpaludismeHAL · Unilimdocument de 106 observations
31,6 %Among hypertensive participants in Cameroon, 31.6% [95% CI 21.0–42.3] were aware of their status during 2011–2018.
Camerounhypertension artérielleobservé 2011-2018publié 2019Journal of hypertensioneurope_pmcdocument de 20 observationsDOI 10.1097/hjh.0000000000002165
Cameroon reported both Clade I and Clade II mpox cases.
CamerounClade I · Clade II · mpoxAfrica CDCdocument de 11 observations
6 %Cameroon population has an estimated 6% affected by diabetes.
Cameroundiabète (non précisé)publié 2016BMC public healtheurope_pmcdocument de 12 observationsDOI 10.1186/s12889-016-3090-1
36,8 %The prevalence of hypertension among HIV patients in this study was 36.8%.
Camerounhypertension artériellepublié 2022Medicineeurope_pmcdocument de 12 observations
1,36 %In Pouma Health District, the prevalence of epilepsy recorded by the research team was 1.36%.
CamerounépilepsieHAL · Unilimdocument de 53 observations
47,6 %Insulin could be discontinued in 47.6% of insulin-treated patients with adequate glycaemic control (HbA1c 6.7 +/- 1.3%).
Cameroundiabète (non précisé)publié 2002Diabetic medicine : a journal of the British Diabetic Associationeurope_pmcdocument de 5 observations
1,3 %Age-standardized prevalence of current wheeze in the previous year was 1.3% to 2.5% in adults in Cameroon.
Camerouncurrent wheezepublié 2004Tropical doctoreurope_pmcdocument de 10 observations
39 000 peopleIn 2013, about 39,000 people in the Africa Region (AFR) suffered from type 1 diabetes.
Cameroundiabète de type 1observé 2013publié 2014Diabetes research and clinical practiceeurope_pmcdocument de 14 observations
69,7 %Among 76 patients followed-up at endpoint, 69.7% had viremia <40 copies/ml.
CamerounVIH/sidaobservé 2009-2011publié 2013PLoS ONEOpenAlexdocument de 8 observationsDOI 10.1371/journal.pone.0072680
2 %The age-standardized diabetes prevalence using WHO criteria was 2.0% in urban Cameroon.
Cameroundiabète (non précisé)publié 1999Diabetes careeurope_pmcdocument de 12 observations
None of the normal subjects had thyroid autoantibodies.
Camerounthyroid autoantibodiespublié 2006Clinical immunology (Orlando, Fla.)europe_pmcdocument de 10 observations
50 %Le PSNLP 2007-2010 visait à réduire de 50 % la morbidité et la mortalité liées au paludisme en particulier dans les populations à risque d’ici 2010.
Camerounpaludismeobservé 2010HAL · Unilimdocument de 98 observations
23 kg/m2The age-standardized mean BMI increased from 23.0 kg/m2 to 23.0 kg/m2 in men in sub-Saharan African countries between 1980 and 2014.
Camerounbody mass indexobservé 2014publié 2017International journal of epidemiologyeurope_pmcdocument de 11 observationsDOI 10.1093/ije/dyx078
0,6 %HIV-1 group O prevalence in Cameroon was around 0.6% (95% confidence interval: 0.4–0.8%).
CamerounHIV-1 group Oobservé 2006 to 2013publié 2015Infection, genetics and evolution : journal of molecular epidemiology and evolutionary geneurope_pmcdocument de 4 observations
17,7 %Prevalence of type 2 diabetes mellitus in men in Saudi Arabia was estimated at 17.7% in 2000 by the Markov model.
Cameroundiabète de type 2observé 2000publié 2014Diabetes research and clinical practiceeurope_pmcdocument de 7 observations
0,8 %The age-standardized diabetes prevalence using WHO criteria was 0.8% in rural Cameroon.
Cameroundiabète (non précisé)publié 1999Diabetes careeurope_pmcdocument de 12 observations
17 001 casEntre janvier et juillet 2018, 17 001 cas de paludisme simple ont été testés à Bafia.
Camerounpaludismeobservé janvier à juillet 2018HAL · Unilimdocument de 67 observations
36 %Le paludisme est responsable de 36 % des cas vus en consultation externe au Cameroun selon les rapports d’activités du PNLP de 2006.
Camerounpaludismeobservé 2006HAL · Unilimdocument de 98 observations
3 %Heart failure accounts for 3%-7% of hospital admission in general internal medicine in sub-Saharan Africa.
Camerouninsuffisance cardiaquepublié 2008Vascular health and risk managementeurope_pmcdocument de 3 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.